pilot
studi
undertaken
examin
whether
kill
influenza
vaccin
caus
exacerb
asthmat
adult
thirtythre
stabl
asthmat
record
peak
expiratori
flow
pef
asthma
symptom
use
asthma
medic
week
receiv
kill
influenza
vaccin
thereaft
record
pef
asthma
symptom
use
medic
week
comparison
record
week
vaccin
reveal
intuenza
vaccin
associ
reduct
pef
po
increas
asthma
symptom
poi
use
asthma
medic
po
similar
result
pef
asthma
symptom
po
asthma
medic
po
obtain
analysi
restrict
day
vaccin
elsevi
scienc
ltd
recogn
caus
asthma
depart
health
doh
strongli
recommend
annual
vaccin
patient
asthma
asthmat
immun
concern
vaccin
safeti
among
asthmat
exemplifi
two
recent
bronchoprovoc
test
reveal
increas
bronchial
reactiv
asthmat
first
day
follow
influenza
immun
j
although
steniusaarniala
et
al
observ
clinic
asthma
exacerb
conflict
result
obtain
accordingli
doh
plan
undertak
multicentr
doubleblind
placebocontrol
crossov
studi
assess
whether
influenza
vaccin
caus
asthma
exacerb
report
result
pilot
studi
studi
conduct
octob
novemb
involv
volunt
stabl
asthma
attend
respiratori
clinic
leicest
studi
size
provid
power
excess
detect
drop
mean
peak
expiratori
flow
pef
percentag
predict
ethic
approv
obtain
local
research
ethic
committe
inform
consent
obtain
patient
patient
told
aim
studi
reaffirm
influenza
vaccin
safeti
asthmat
patient
given
asmaplan
peak
flow
meter
vitalograph
ltd
uk
diari
card
instruct
record
best
three
pef
morn
min
medic
last
thing
night
total
number
dose
asthma
medic
taken
everi
day
asthma
symptom
includ
night
cough
daytim
cough
chest
tight
wheez
short
breath
sleep
disturb
result
chest
symptom
accord
follow
score
oabsent
patient
instruct
telephon
research
team
develop
drop
pef
order
obtain
sampl
virolog
nose
throat
swab
test
presenc
rhinovirus
enterovirus
describ
previous
pair
acut
convalesc
sera
test
complement
fix
antibodi
adenoviru
influenza
b
respiratori
syncyti
viru
parainfluenza
virus
mycoplusma
pneumonia
chlamydia
psittaci
elisa
use
detect
antibodi
rise
coronavirus
end
second
week
patient
vaccin
commerci
avail
influenza
vaccin
season
continu
record
pef
asthma
symptom
medic
anoth
week
mean
morn
prebronchodil
applic
pef
percentag
predict
valu
vaccin
compar
use
pair
ttest
wilcoxon
sign
rank
test
use
compar
mean
asthma
symptom
score
vaccin
mean
daili
dose
asthma
medic
vaccin
thirti
three
patient
male
median
age
year
rang
complet
studi
patient
mean
pef
percentag
predict
rang
twentyon
patient
requir
regular
treatment
inhal
b
adrenoceptor
stimul
patient
use
inhal
steroid
regularli
eight
patient
also
took
oral
steroid
eleven
patient
receiv
influenza
vaccin
previous
differ
mean
preand
postvaccin
pef
percentag
predict
statist
signific
whole
studi
period
ci
day
vaccin
ci
differ
mean
preand
postvaccin
asthma
symptom
score
signific
whole
studi
period
ci
day
vaccin
ci
differ
mean
daili
dose
asthma
medic
signific
whole
studi
period
ci
day
vacciant
ci
one
patient
report
system
upper
respiratori
tract
symptom
accompani
drop
pef
day
vaccin
last
day
first
contact
research
team
day
vaccin
document
upper
respiratori
symptom
accompani
drop
pef
last
day
specimen
diagnost
virolog
obtain
day
fail
detect
respiratori
pathogen
discuss
find
import
consid
potenti
strength
limit
studi
studi
control
pef
meter
use
data
log
code
may
potenti
incorrect
record
patient
studi
volunt
attend
secondari
centr
manag
asthma
therefor
may
repres
sampl
stabl
asthmat
furthermor
onethird
subject
vaccin
previous
may
introduc
bia
may
self
select
bad
respons
nevertheless
patient
display
wide
rang
asthma
sever
morn
prebronchodil
pef
percentag
predict
rang
eight
patient
maintain
oral
steroid
inocul
kill
influenza
vaccin
caus
exacerb
group
patient
stabl
asthma
agreement
previou
contrast
find
studi
undertaken
bell
et
examin
possibl
clinic
signific
deterior
symptom
lung
function
increas
need
medic
occur
first
day
immun
comparison
data
longer
period
mask
chang
found
support
explan
studi
although
overal
evid
asthma
exacerb
one
patient
deterior
asthma
control
symptom
upper
respiratori
tract
infect
associ
respiratori
virus
exacerb
asthma
well
howev
fai
ed
identifi
respiratori
viral
pathogen
case
may
interv
onset
symptom
sampl
howev
exclud
advers
reaction
vaccin
clearli
larg
placebocontrol
studi
need
demonstr
advers
pulmonari
reaction
vaccin
occur
occur
less
frequent
pulmonari
function
abnorm
would
expect
averag
winter
absenc
influenza
vaccin
